Boundless Bio, Inc.
BOLD
$2.83
$0.061.98%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -51.15% | 13.98% | 21.66% | 15.93% | 7.66% |
| Total Depreciation and Amortization | 296.53% | -10.41% | 3.72% | 18.32% | 19.62% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 500.28% | 1.58% | -4.37% | 12.03% | 71.19% |
| Change in Net Operating Assets | -652.31% | -284.90% | 173.80% | 14.15% | 391.48% |
| Cash from Operations | -77.30% | -3.04% | 35.06% | 23.15% | 27.14% |
| Capital Expenditure | 20.83% | 86.44% | 9.01% | 96.89% | 96.81% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 103.77% | 367.94% | 485.19% | -53.60% | 117.00% |
| Cash from Investing | 104.30% | 376.70% | 611.52% | -52.65% | 116.56% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -37.61% | -- | -78.76% | -- | -99.87% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -37.61% | -- | -78.76% | 100.00% | -99.87% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 616.67% | 96.64% | 121.19% | -96.80% | -106.75% |